STREAMEX CORP. Defined Contribution Plan, Cost
STREAMEX CORP. (STEX) reported Defined Contribution Plan, Cost of $21.69 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2024-05-20
- STREAMEX CORP. defined contribution plan, cost for the quarter ending 2024-03-31 was $21.69K, a 67.09% decline year-over-year.
- STREAMEX CORP. defined contribution plan, cost for the quarter ending 2023-12-31 was $43.93K, a 20.20% decline year-over-year.
- STREAMEX CORP. defined contribution plan, cost for the quarter ending 2023-09-30 was $56.08K, a 1.69% decline year-over-year.
- STREAMEX CORP. defined contribution plan, cost for the quarter ending 2023-06-30 was $63.82K, a 6.00% decline year-over-year.
- STREAMEX CORP. defined contribution plan, cost for fiscal 2023 was $229.74K, a 7.22% decline from fiscal 2022.
- STREAMEX CORP. defined contribution plan, cost for fiscal 2022 was $247.62K, a 1.91% decline from fiscal 2021.
- STREAMEX CORP. defined contribution plan, cost for fiscal 2021 was $252.45K, a 48.22% increase from fiscal 2020.
- STREAMEX CORP. defined contribution plan, cost for fiscal 2020 was $170.32K, a 54.21% increase from fiscal 2019.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 6 month | Defined Contribution Plan, Cost 9 month | Defined Contribution Plan, Cost 12 month |
|---|---|---|---|---|
| 2024-03-31 | $21.69K 10-Q · filed 2024-05-20 | $65.62K derived: sum of 2 quarters · filed 2024-05-20 | $121.70K derived: sum of 3 quarters · filed 2024-05-20 | $185.52K derived: sum of 4 quarters · filed 2024-05-20 |
| 2023-12-31 | $43.93K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $100.01K derived: sum of 2 quarters · filed 2024-04-16 | $163.82K derived: sum of 3 quarters · filed 2024-04-16 | $229.74K 10-K · filed 2024-04-16 |
| 2023-09-30 | $56.08K 10-Q · filed 2023-11-14 | $119.90K derived: sum of 2 quarters · filed 2023-11-14 | $185.81K 10-Q · filed 2023-11-14 | $240.87K derived: sum of 4 quarters · filed 2024-05-20 |
| 2023-06-30 | $63.82K 10-Q · filed 2023-08-14 | $129.74K 10-Q · filed 2023-08-14 | $184.79K derived: sum of 3 quarters · filed 2024-05-20 | $241.83K derived: sum of 4 quarters · filed 2024-05-20 |
| 2023-03-31 | $65.92K 10-Q · filed 2024-05-20 | $120.97K derived: sum of 2 quarters · filed 2024-05-20 | $178.01K derived: sum of 3 quarters · filed 2024-05-20 | $245.90K derived: sum of 4 quarters · filed 2024-05-20 |
| 2022-12-31 | $55.05K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $112.09K derived: sum of 2 quarters · filed 2024-04-16 | $179.98K derived: sum of 3 quarters · filed 2024-04-16 | $247.62K 10-K · filed 2024-04-16 |
| 2022-09-30 | $57.04K 10-Q · filed 2023-11-14 | $124.93K derived: sum of 2 quarters · filed 2023-11-14 | $192.57K 10-Q · filed 2023-11-14 | $255.28K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $67.89K 10-Q · filed 2023-08-14 | $135.53K 10-Q · filed 2023-08-14 | $198.24K derived: sum of 3 quarters · filed 2023-08-14 | $259.55K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $67.64K 10-Q · filed 2023-05-15 | $130.35K derived: sum of 2 quarters · filed 2023-05-15 | $191.66K derived: sum of 3 quarters · filed 2023-05-15 | $248.63K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $62.71K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $124.03K derived: sum of 2 quarters · filed 2023-03-31 | $180.99K derived: sum of 3 quarters · filed 2023-03-31 | $252.45K 10-K · filed 2023-03-31 |
| 2021-09-30 | $61.31K 10-Q · filed 2022-11-14 | $118.28K derived: sum of 2 quarters · filed 2022-11-14 | $189.74K 10-Q · filed 2022-11-14 | $229.03K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $56.96K 10-Q · filed 2022-08-15 | $128.43K 10-Q · filed 2022-08-15 | $167.72K derived: sum of 3 quarters · filed 2022-08-15 | $217.06K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $71.47K 10-Q · filed 2022-05-16 | $110.76K derived: sum of 2 quarters · filed 2022-05-16 | $160.10K derived: sum of 3 quarters · filed 2022-05-16 | $203.58K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $39.29K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $88.63K derived: sum of 2 quarters · filed 2022-03-31 | $132.12K derived: sum of 3 quarters · filed 2022-03-31 | $170.32K 10-K · filed 2022-03-31 |
| 2020-09-30 | $49.34K 10-Q · filed 2021-11-15 | $92.82K derived: sum of 2 quarters · filed 2021-11-15 | $131.03K 10-Q · filed 2021-11-15 | $171.48K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $43.48K 10-Q · filed 2021-08-11 | $81.68K 10-Q · filed 2021-08-11 | $122.14K derived: sum of 3 quarters · filed 2021-08-11 | $153.32K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $38.20K 10-Q · filed 2021-05-17 | $78.66K derived: sum of 2 quarters · filed 2021-05-17 | $109.83K derived: sum of 3 quarters · filed 2021-05-17 | $133.86K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $40.45K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $71.63K derived: sum of 2 quarters · filed 2021-03-15 | $95.66K derived: sum of 3 quarters · filed 2021-03-15 | $110.44K 10-K · filed 2021-03-15 |
| 2019-09-30 | $31.18K 10-Q · filed 2020-11-05 | $55.21K derived: sum of 2 quarters · filed 2020-11-05 | $69.99K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $24.03K 10-Q · filed 2020-08-06 | $38.81K 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |